CBD Technologies Ltd. (now a FuturaGene company)

www.cbdtech.com

Now Suzano Israel

High-Tech Company

Acquired by FuturaGene

TECH VERTICALS

AgriBiotech, AgriTech

General Data

Sector	Agritech
Company Stage:	R&D
Established	1993
Number of Employees	8

DESCRIPTION

CBD Technology develops a broad application generating platform based on Cellulose Binding Domain (CBD) Technology. Protein-engineering focus areas for product, process and application development include bioseparation (antibody purification, sample capture for rare analyte diagnostics and analysis), bioprocessing (single-step enzyme purification and immobilization for the production of pharma intermediates, bioremediation). Gene-driven applications are focussed on the modulation of plant growth by intervention in cellulose biosynthesis. Growth modulation is focussed on increased biomass (forestry, forage crops), altered digestibility and carbohydrate properties in plants.

	TARGET MARKETS
	Main Markets: Diagnostics, Bioseparation, Bioprocess, Biopharmaceutics, Agbiotech

	BUSINESS MODEL
	B2B

REMARKS

Date	Remark
01/11/2006	FuturaGene Plc. acquired CBD Technologies Ltd. and turned it into its Israeli R&D center.

CONTACT INFO

Expand / Collapse All

Main Address: Rehovot, Israel

Address	2 Pekeris St., Tamar Science Park
POB	199
City	Rehovot
Country	Israel
Zip	76100

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: New Jersey, United States

Address	Bergenfield
POB	484
City	New Jersey
State/Province	NJ
Country	United States
Zip	07621

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Mr. Mordechai Bignitz	SVP & CFO	SR Accord Technologies (CEO of Subsidiary & Investmet Banking)
Dr. Stanley Hirsch	Co-Founder	Rimonyx (Business Advisor)
Prof. Oded Shoseyov	Co-Founder	BondX (CSO)

Mergers & Acquisitions

Round

Date

Stage

Amount

Valuation

Acquired

Nov. 26, 2006

abCDe

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Third Round

May. 28, 2002

R&D

abCDe

Other

Mar. 26, 2002

R&D

abCDe

Second Round

Jun. 01, 1998

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Corporate VC	abCDe
abC Defghij	Corporate VC	abCDe
abC Defghij	Investment Company	abCDe
abC Defghij	Investment Company	abCDe	Holds 4.8% of the company
abC Defghij	Investment Company	abCDe

First Round

Jan. 01, 1996

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Other	abCDe
abC Defghij	Other	abCDe

Seed

Jan. 01, 1994

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Technology Transfer Company	abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

May. 14, 2000

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Bi-National Fund	abCDe	R&D grant

Last Updated:	abCDe
IVC Number:	abCDe